# Therapak Corporation – FDA Inspection, Feb 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/therapak-corporation/3552cdb8-8d0f-4317-82d6-d64cb29b703a
Source feed: FDA_Inspections

> FDA inspection 1304602 of Therapak Corporation, February 12, 2026. Classification: Voluntary Action Indicated (VAI). 2 citations. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304602
- Company Name: Therapak Corporation
- Inspection Date: 2026-02-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Product Evaluation: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1119689 - 2020-02-05
- FDA Inspection 1055427 - 2017-12-05
- [FDA Inspection 925747 - 2015-04-24](https://www.keypedia.com/records/fda_inspections/therapak-corporation/96c195cf-89b6-4b3a-a4ae-d93374ab1f38)
- [FDA Inspection 675392 - 2010-06-29](https://www.keypedia.com/records/fda_inspections/therapak-corporation/8522fa1c-5b9a-462e-a125-9d3bfe153db0)

## Related Officers

- [Linda Galindo](https://www.keypedia.com/people/linda-galindo/6bc29df6-192b-4d89-92ae-20cc1660d9ad)

Company: https://www.keypedia.com/companies/therapak-corporation/1a9ffab2-008a-4396-9e24-94bdc8fa916e

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
